KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Progyny (PGNY) Total Non-Current Liabilities (2018 - 2022)

Historic Total Non-Current Liabilities for Progyny (PGNY) over the last 5 years, with Q1 2022 value amounting to $135.9 million.

  • Progyny's Total Non-Current Liabilities rose 2457.7% to $135.9 million in Q1 2022 from the same period last year, while for Mar 2022 it was $135.9 million, marking a year-over-year increase of 2457.7%. This contributed to the annual value of $106.2 million for FY2021, which is 2338.92% up from last year.
  • Latest data reveals that Progyny reported Total Non-Current Liabilities of $135.9 million as of Q1 2022, which was up 2457.7% from $106.2 million recorded in Q4 2021.
  • In the past 5 years, Progyny's Total Non-Current Liabilities registered a high of $135.9 million during Q1 2022, and its lowest value of $25.6 million during Q4 2018.
  • For the 5-year period, Progyny's Total Non-Current Liabilities averaged around $80.9 million, with its median value being $86.1 million (2020).
  • In the last 5 years, Progyny's Total Non-Current Liabilities soared by 13809.97% in 2020 and then surged by 2338.92% in 2021.
  • Over the past 5 years, Progyny's Total Non-Current Liabilities (Quarter) stood at $25.6 million in 2018, then surged by 41.19% to $36.2 million in 2019, then surged by 138.1% to $86.1 million in 2020, then grew by 23.39% to $106.2 million in 2021, then increased by 27.92% to $135.9 million in 2022.
  • Its last three reported values are $135.9 million in Q1 2022, $106.2 million for Q4 2021, and $112.1 million during Q3 2021.